Aspire-Lakewood Holdings, Inc. (ASBP) stock
ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
$8.30+0.24 (+2.98%)
Close on Nov 17, 2026Market cap $11.64MP/E –Yield –
Earnings
Aspire-Lakewood's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Aspire-Lakewood's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Aspire-Lakewood has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Aspire-Lakewood puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Aspire-Lakewood filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- News
- News
- News
See a number that looks wrong?